IP Library Granted Patent US 8,697,378
Granted Patent B2
US 8,697,378 · App. 12/065,125 · Granted Apr 15, 2014

Method and kit for quantitative determination for small, dense particle low density lipoproteins

Inventor: Yasuki Itoh (Niigata, JP)
Assignee: Denka Seiken Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,697,378
App. No.
12/065,125
Granted
Apr 15, 2014
Kind
B2
Abstract

A rapid and convenient method capable of performing fractional measurement of small, dense LDLs without pretreatment of a specimen, which is adaptable for an autoanalyzer, is provided. A method for quantitatively determining small, dense LDL cholesterol is provided, which comprises adding enzymes for cholesterol measurement to a test sample in the presence of a polyoxyethylene-polyoxypropylene copolymer or a derivative thereof, causing the polyoxyethylene-polyoxypropylene copolymer or the derivative thereof to selectively act on small, dense LDLs among lipoproteins, and then measuring the amount of cholesterol generated.

Claims (11)

1. A method for quantitatively determining small, dense LDL cholesterol, comprising:

adding enzymes for cholesterol measurement to a test sample in the presence of a polyoxyethylene-polyoxypropylene copolymer represented by formula (II):

RO—(C 3 H 6 O) d —(C 2 H 4 O) e —(C 3 H 6 O) f —H  (II),

wherein a is an integer between 1 and 200, b is an integer between 1 and 200, c is an integer between 1 and 200, d is an integer between 1 and 60, e is an integer between 20 and 100, and f is an integer between 1 and 60,

wherein R denotes a hydrogen atom or linear or branched alkyl having a carbon number ranging from C1 to C30;

(ii) causing the polyoxyethylene-polyoxypropylene copolymer to selectively act on small, dense LDLs among lipoproteins, and then

(iii) measuring the amount of cholesterol generated.

2. The method according to claim 1 , comprising further adding a nonionic and/or anionic surfactant.

3. The method according to claim 1 , wherein the enzymes for cholesterol measurement comprise cholesterol esterase as well as cholesterol oxidase or cholesterol dehydrogenase.

4. The method according to claim 1 , further comprising adding phospholipase and/or lipoprotein lipase.

5. The method according to claim 1 , further comprising, before step (ii), eliminating or aggregating cholesterols other than small, dense LDLs.

Assignments (2)
MERGER Recorded Oct 5, 2020
From: DENKA SEIKEN CO., LTD.
To: DENKA COMPANY LIMITED
Reel/Frame 053976/0705 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 28, 2008
From: ITOH, YASUKI
To: DENKA SEIKEN CO., LTD.
Reel/Frame 020575/0799 →
Priority Claims (1)
JP 2005-252091 · Aug 31, 2005 · national
Continuity (1)
Related Publication 20090263844A1 · Oct 22, 2009